Avendus is a financial services firm that provides investment banking, wealth management, credit solutions, and asset management services.

Avendus

Avendus - Enterprise Tech & Services

Avendus Capital Pvt. Ltd is a leading financial services firm, which along with its associates, provides
customized solutions in the areas of financial advisory, equity capital markets, wealth management and alternative asset management. The firm relies on its extensive track record, in-depth domain understanding and knowledge of the economic and regulatory environment, to offer research based solutions to its clients that include institutional investors, corporations and high net worth individuals/families. In recent years, Avendus Capital Pvt. Ltd. has consistently been ranked among theleading corporate finance advisors in India and has emerged as the advisor of choice for cross-border M&A deals, having closed around 40 cross-border transactions in the past 5 years. Avendus Wealth Management Pvt. Ltd. caters to investment advisory and portfolio management needs of Family offices and Ultra High Net worth Individuals / families, spanning all asset classes. Headquartered in Mumbai, the firm has offices in New Delhi and Bangalore.

Avendus Capital, Inc (US) and Avendus Capital (UK) Pvt. Ltd. located in New York and London respectively are wholly owned subsidiaries of Avendus Capital Pvt. Ltd offering M&A and Private Equity syndication services in the respective regions. Avendus Capital, Inc (US) also provides wealth management services in select jurisdictions in USA.

Bikaji Foods

SBI Life

SMAAASH

Deepak Fertilisers

EuroKids International

Kohlberg Kravis Roberts

Gaja Capital

Yogesh Mahansaria

🚨Please be advised, we, Avendus Group, its affiliate entities and its employees are in no manner associated with the fraudulent WhatsApp groups, fake websites, Instagram/Facebook ads created for misusing our name and impersonating us and our employee, Mr. Naresh Rathi. Avendus Group does not create or subscribe to any such fake/fraudulent websites or groups on any third-party apps like WhatsApp, Telegram etc. that deal in stock market information or tips.
 
With the surge in cyber crimes, of late, we urge everyone including our clients to be vigilant and only trust communication from your Avendus relationship manager.
 
#StaySafe

We are thrilled to announce that Avendus has won the ICICI Lombard-CNBC TV18 India Risk Management Award as Masters of Risk in Risk Governance. This prestigious accolade recognizes our excellence in risk that drives our decision-making and strategies. Winning this award for the third consecutive year underscores our commitment to best-in-class risk management practices, ensuring resilience and adaptability in an ever-changing business landscape, while always prioritizing the interests of our clients, shareholders, and employees.

Cheers to our risk team for their outstanding contribution as solid pillars of our risk function!
 
ICICI Lombard General Insurance Company Limited I CNBC-TV18
 
Latha Venkatesh I Sanjeev Mantri

Dhiren Mehta I Divya Sangle I Arthi Swaminathan I Jatin Doshi I Shashank Dixit I Gangadhar Vedula I Irina Goel I Amey Mahadik

#RiskManagement #MastersOfRisk #RiskGovernance #CorporateGovernance #Regulations #Compliance

Avendus Future Leaders Fund (FLF) III aims to raise a corpus of Rs 3,000 crores, including a green-shoe option of up to Rs 1,500 crores. Ritesh Chandra, Managing Partner, Avendus Future Leaders Fund, elaborates on FLF III's investment plans in an interview on CNBC-TV18’s Startup Street. He discusses the target sectors poised for sustained growth over the next decade which includes financial services, consumption, digital & technology, healthcare, and manufacturing. He also talks about a notable shift towards prioritizing sustainable profitability and unit margins, which reflects a more robust private market ecosystem. Watch here👉https://lnkd.in/dxRWBTVM
 
#FutureLeaders #Fund #Investment #PrivateEquity #FinancialServices #Consumption #Digital #Technology #Healthcare #Manufacturing

💡#AvendusEye: The Indian Domestic Formulations market is expected to reach INR ~5.5 trillion by 2034, growing at a CAGR of 10%. While India has earned its rightful title as the pharmacy to the world, there remains a significant under penetration in the domestic market. In our opinion, the next phase of growth will be driven by improving affordability, awareness and medication adherence, as well as successfully penetrating tier 2+ regions. We also foresee fundamental shifts in operating models, including alternative marketing and channel strategies with increased adoption of TGx and GxGx to counter the proposed and expected regulatory changes. The next decade will require skillful navigation. On this note, we are happy to unveil our latest research on the DomForm sector. Download now👉https://lnkd.in/d5jsZmAP

📩 Want to know more about India's DomForm potential? Write to us at 
hc@avendus.com 

✍: Anshul Gupta I Prasshanth Hari I Pushkaraj Dhake I Sushant Kabra I Shubham Bageshwar I Ashish Tiwari
 
#DomesticFormulations #DomForm #Pharma #Generics #Medicines #Healthcare #InvestmentBanking

Meet the latest addition to our Investment Banking team - the all-stars Associates batch of 2024! Hailing from India’s top B-schools and channelling their favourite superheroes, they are all set to take centre stage in the world of IB. Each of them brings a wealth of dynamism and innovative thinking to the table and we’re excited to see them in action. Here’s what they had to say about why they decided to be an Avender👇  

Indian Institute of Management Ahmedabad: Ashvini Kumar | Neelay Jain | Sucharitha Melarkode | Viraj Yadav 
 
Indian Institute of Management Bangalore: Adithya Kasamsetty | Prit Shah
 
Indian Institute of Management, Calcutta: Abhiraj Parashari | Nischal Singhal I Aravind DS I Vrishank Bhardwaj
 
Indian Institute of Management, Lucknow: Aakriti Jain | Arav S.| Arpit Maheshwari | Hardil Vora
 
#Associates #FutureLeaders #Culture #LifeAtAvendus #InvestmentBanking #NextIsTheOnlyLevel

The weekend is here and we’ve wrapped up an exciting week at Avendus. We organized the DomForm Summit, playing host to seasoned entrepreneurs, promoters and professionals from the Indian pharma industry. We also unveiled our comprehensive research report on the Domestic Formulations sector, diving into the market opportunity, expansion avenues and significant regulatory interventions that will propel the industry forward. Download your copy of the report here👉https://lnkd.in/d5jsZmAP

Here’s a throwback to the evening.👇 

Sudarshan Jain (Indian Pharmaceutical Alliance) | Amit Bakshi (ERIS Lifesciences) | Nikhil Chopra (JB) I Sanjiv Navangul (Bharat Serums and Vaccines Limited) | Mrinalini Mirchandani (McKinsey & Company)

Anshul Gupta I Prasshanth Hari I Pushkaraj Dhake I Sushant Kabra I Shubham Bageshwar I Ashish Tiwari

#DomForm #DomesticFormulations #Pharma #Healthcare #InvestmentBanking #NextIsTheOnlyLevel

COM:AVENDUS

Avendus

Analysis Not Available